SAFETY, EFFICACY AND RISK OF COMPLICATIONS FOR CIRRHOTIC HCV PATIENTS WITH THROMBOCYTOPENIA AND HYPOALBUMINEMIA TREATED WITH OMBITASVIR/PARITAPREVIR/R+DASABUVIR+RIBAVIRIN  – A REAL LIFE COHORT

Carmen-Cristina Ester  1     Liliana Simona Gheorghe  1     Speranta Iacob  2     Cristina Cijevschi  3     Anca-Victorita Trifan  4     Carol Stanciu  5     Ioan Sporea  6     Roxana Lucia Denisa Sirli     Manuela Curescu     Cirpian Brisc     Eugen-Adrian Goldis     Victoria Arama     Florin Alexandru Caruntu     Ion Rogoveanu     Andrada Seicean     IULIA SIMIONOV     Roxana Vadan     Iulia    
1 Fundeni Clinical Institute,Bucharest,Romania
2 Fundeni Clinical Institute,Bucuresti,Romania
3 UMF Iasi,Iasi,Romania
4 "Grigore T. Popa" University of Medicine and Pharmacy Iasi,Gastroenterology,Iasi,Romania
5 Institute of Gastroenterology and Hepatology,Iasi,Romania
6 University of Medicine an

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing